The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 276.00
Bid: 273.50
Ask: 274.00
Change: -0.50 (-0.18%)
Spread: 0.50 (0.183%)
Open: 272.50
High: 276.00
Low: 272.50
Prev. Close: 276.50
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report - December 2023

12 Jan 2024 07:00

RNS Number : 4194Z
Ruffer Investment Company Limited
12 January 2024
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for December 2023.

 

http://www.rns-pdf.londonstockexchange.com/rns/4194Z_1-2024-1-11.pdf

 

Christmas arrived early for asset owners last year, as December saw US equities approach all-time highs and the bond rally continue. The Federal Reserve provided the festive cheer, by pivoting their message from 'higher for longer' interest rates to 'lower, sooner', projecting three cuts in 2024 thanks to falling inflation. This reinforced the market's soft-landing narrative and drove a US-centric Santa rally. Elsewhere, the Bank of Japan left policy unchanged despite significant noise, and investors remained unimpressed by the lack of concrete stimulus measures in China.

 

As was the case in November, the fund's fixed income holdings were the largest contributor - adding over 1.5% to performance. Yields continued to fall as the Chair of the Federal Reserve assured markets that they were unlikely to raise interest rates any further, taking the US ten year bond yield to 3.9%, down more than 1% since October. Our US exposure participated in the rally as the market broadened out from the 'Magnificent 7' technology stocks. Gold exposure was helpful, as the metal reached new highs. Meanwhile, the yen managed to gain over 4% against both the US dollar and the pound, despite the Bank of Japan leaving their loose monetary policy intact, adding over half a percent to performance in addition to gains from our yen call options. However, despite making positive returns in both December and the final quarter of 2023, the fund continued to face headwinds from its protective positions, which suffered as equities rose and credit spreads narrowed.

 

It continues to be our belief that tighter liquidity conditions present a significant risk to markets. Accordingly, we have reduced the fund's duration by roughly half from its recent peak, with sales of US bonds and gold bullion. This felt prudent given the bond market is now pricing six interest rate cuts in 2024, double the amount anticipated by the Fed. We believe a soft landing is now close to fully priced, leaving the market exposed to any pushback from policymakers or the data.

 

We maintain the view that it is too early to declare a soft-landing victory. Even if the probability of this outcome has increased, market pricing has moved even further, creating an asymmetry in asset prices. We think the scenario in which the market's six interest rate cuts are validated, is the arrival of recession. However, a soft landing is not an impossibility, and the fund holds over 20% across equities and commodities which should benefit from a broader market rally and further economic strength. This is also supported by the remaining fixed income positions and gold equities, which should rise in value if yields fall further.

 

Portfolio balance, which was painfully elusive at points last year, is now much more secure - evident in recent months as markets have rallied and the fund has delivered a positive return, despite its defensive positioning. Crucially though, if liquidity conditions and the economy do deteriorate, our derivative holdings - primarily credit protection and exposure to the VIX, should appreciate sharply. There were glimmers of this mid-month, as a small but sharp one day sell-off in the S&P saw the VIX index spike 12% intraday. 

 

Overall, we enter the new year with the mindset that we are continuing to travel towards the danger, rather than away from it, and we will not let a disappointing 2023 obscure what we see in front of us.

 

An error in calculation of the NAV total return since inception has led to the figure being understated by c 3% in the monthly reports published between July and December 2023. The performance methodology has been updated to remediate this error and the NAV total return since inception figure in this report is correct. Please note that this notice does not affect any of the published NAVs.

 

 

Enquiries:

Sanne Fund Services (Guernsey) Limited

Jamie Dodd

Email: RIC@apexfs.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAOURSVUAAAR
Date   Source Headline
14th Nov 20237:00 amRNSMonthly Investment Report - October 2023
8th Nov 20232:03 pmRNSNet Asset Value(s)
1st Nov 20231:17 pmRNSNet Asset Value(s)
27th Oct 20234:00 pmRNSNotice of AGM
25th Oct 20231:33 pmRNSNet Asset Value(s)
18th Oct 202312:47 pmRNSNet Asset Value(s)
11th Oct 20233:04 pmRNSNet Asset Value(s)
6th Oct 20233:48 pmRNSMonthly Investment Report - September 2023
4th Oct 202312:58 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSAnnual Financial Report
3rd Oct 20234:35 pmRNSDividend Declaration
2nd Oct 20235:27 pmRNSNet Asset Value(s)
27th Sep 20231:10 pmRNSNet Asset Value(s)
20th Sep 202312:32 pmRNSNet Asset Value(s)
13th Sep 20234:45 pmRNSBlock listing Interim Review
13th Sep 20232:34 pmRNSNet Asset Value(s)
11th Sep 20237:00 amRNSMonthly Investment Report - August 2023
1st Sep 202312:27 pmRNSNet Asset Value(s)
31st Aug 20234:30 pmRNSTotal Voting Rights
30th Aug 202311:11 amRNSNet Asset Value(s)
23rd Aug 20231:00 pmRNSNet Asset Value(s)
23rd Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20233:30 pmRNSNet Asset Value(s)
10th Aug 20237:00 amRNSMonthly Investment Report - July 2023
9th Aug 20233:05 pmRNSNet Asset Value(s)
2nd Aug 20232:51 pmRNSNet Asset Value(s)
1st Aug 20233:49 pmRNSNet Asset Value(s)
26th Jul 20232:02 pmRNSNet Asset Value(s)
19th Jul 20232:48 pmRNSNet Asset Value(s)
17th Jul 20237:00 amRNSInvestment Manager's Year End Review
12th Jul 20231:17 pmRNSNet Asset Value(s)
10th Jul 20237:00 amRNSMonthly Investment Report - June 2023
7th Jul 202311:56 amRNSFund Manager Share Purchase
5th Jul 20231:48 pmRNSNet Asset Value(s)
3rd Jul 20233:13 pmRNSNet Asset Value(s)
28th Jun 20233:19 pmRNSNet Asset Value(s)
22nd Jun 20237:00 amRNSKepler Trust Intelligence: New Research
21st Jun 20233:07 pmRNSNet Asset Value(s)
20th Jun 20232:51 pmRNSDirector Declaration
20th Jun 202312:00 pmRNSMonthly Investment Report - May 2023
14th Jun 20232:26 pmRNSNet Asset Value(s)
7th Jun 20233:23 pmRNSNet Asset Value(s)
1st Jun 20233:22 pmRNSNet Asset Value(s)
31st May 20235:27 pmRNSTotal Voting Rights
31st May 20232:31 pmRNSNet Asset Value(s)
26th May 20232:28 pmRNSDirector/PDMR Shareholding
24th May 20233:14 pmRNSNet Asset Value(s)
17th May 20234:30 pmRNSMonthly Investment Report - April 2023
17th May 20232:49 pmRNSNet Asset Value(s)
11th May 20234:46 pmRNSIssue of Equity & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.